EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Association between subclinical haemolysis and periprocedural outcomes in patients undergoing transcatheter aortic valve replacement

Gloria Heredia-Campos, Rafael Gonzalez-Manzanares, Ana Rodríguez-Almodovar, Juan Antonio Moreno, Isabel Pozuelo, Jorge Perea, Ignacio Gallo, Luis Carlos Maestre, Francisco Hidalgo, Javier Suárez De Lezo, Miguel Romero, Dolores Mesa und 3 weitere

Medicina Clínica · 2025

DOI: 10.1016/j.medcli.2025.107143 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Medicina Clínica, 2025. Verfasst von Gloria Heredia-Campos und 14 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Cór…. Hauptthemen laut MEDLINE: Hemolysis, Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, Postoperative Complications. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Carlos III Health Institute, Spanish Society of Cardiology, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Transcatheter aortic valve implantation (TAVI) has become a cornerstone treatment for patients with severe aortic stenosis, especially those unsuitable for surgery. Intravascular haemolysis has been described in patients with aortic stenosis. This study aimed to assess the prevalence of haemolysis in patients with severe AS undergoing TAVI and its association with immediate and 30-day post-procedural outcomes. METHODS: The HEMO-TAVI study was a prospective, single-centre cohort study conducted at University Hospital Reina Sofía (Córdoba, Spain) from June 2020 to September 2023. Consecutive patients scheduled for TAVI were enrolled. Haemolysis was defined as LDH>220U/L plus ≥2 criteria (low haemoglobin, low haptoglobin, elevated reticulocytes, or schistocytes). The primary endpoint was a composite of peri-procedural and 30-day adverse events. RESULTS: Among 301 patients, pre-procedural haemolysis was identified in 18 (6.0%). Patients with haemolysis had higher interventricular septum thickness and transvalvular gradients. The composite endpoint occurred more frequently in the haemolysis group (44.4% vs 21.2%, ORadj 2.23, 95% CI 1.12-8.25, p=0.025). Haemolysis was independently associated with a greater number of complications (ORadj 3.26, 95% CI 1.19-8.47, p=0.016). CONCLUSION: Pre-procedural haemolysis might be present in TAVI candidates and is associated with increased peri-procedural and 30-day complications. Pre-procedural haemolysis may serve as a marker of elevated procedural risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemolysisTranscatheter Aortic Valve ReplacementAortic Valve StenosisPostoperative ComplicationsHumansMaleFemaleProspective StudiesAged, 80 and overAgedTreatment OutcomePrevalence

Stichwörter der Autor:innen

Aortic stenosisEstenosis aórticaHaemolysisHemólisisPercutaneous aortic valve replacementPreoperative assessmentPrótesis valvular aórtica percutáneaValoración preoperatoria

Autor:innen und Institutionen

  • Servicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.
  • Servicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain; CIBER de Enfermedades Cardiovasculares, Instituto de Salu…
  • Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain; Departmento de Biología Celular, Fisiología e Inmunología. Universidad de Córdoba, Córdoba, Spain.
  • Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.
  • Servicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain.

Förderung

  • Carlos III Health Institute
  • Spanish Society of Cardiology
  • Instituto de Salud Carlos III
  • Ministerio de Ciencia, Innovación y Universidades
  • Ministerio de Ciencia e Innovación
  • European Commission

Zitieren

APA

Heredia-Campos, G., Gonzalez-Manzanares, R., Rodríguez-Almodovar, A., Moreno, J. A., Pozuelo, I., Perea, J., Gallo, I., Maestre, L. C., Hidalgo, F., De Lezo, J. S., Romero, M., Mesa, D., Espejo, S., Pan, M., & Ojeda, S. (2025). Association between subclinical haemolysis and periprocedural outcomes in patients undergoing transcatheter aortic valve replacement. Medicina Clínica. https://doi.org/10.1016/j.medcli.2025.107143

Vancouver

Heredia-Campos G, Gonzalez-Manzanares R, Rodríguez-Almodovar A, Moreno JA, Pozuelo I, Perea J, et al. Association between subclinical haemolysis and periprocedural outcomes in patients undergoing transcatheter aortic valve replacement. Medicina Clínica. 2025. doi:10.1016/j.medcli.2025.107143

BibTeX
@article{HerediaCampos2025,
  author = {Heredia-Campos, Gloria and Gonzalez-Manzanares, Rafael and Rodríguez-Almodovar, Ana and Moreno, Juan Antonio and Pozuelo, Isabel and Perea, Jorge and Gallo, Ignacio and Maestre, Luis Carlos and Hidalgo, Francisco and De Lezo, Javier Suárez and Romero, Miguel and Mesa, Dolores and Espejo, Simona and Pan, Manuel and Ojeda, Soledad},
  title = {Association between subclinical haemolysis and periprocedural outcomes in patients undergoing transcatheter aortic valve replacement},
  journal = {Medicina Clínica},
  year = {2025},
  doi = {10.1016/j.medcli.2025.107143}
}
Kostenlos starten →